Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Neuhaus

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
British Journal of Pharmacology|May 9, 2009
Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseasesH Schäcke, T M Zollner, W D Döcke, et al.
Zeitschrift Fur Gastroenterologie|September 1, 1992
[Orthotopic liver transplantation in hepatic cirrhosis: on the problem of infection of the transplant with persistent hepatitis viruses]U Hopf, P Neuhaus, V König, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 2, 2012
Role of mannose-binding lectin-2 polymorphism in the development of acute cellular rejection after transplantation for hepatitis C virus-induced liver diseaseD Eurich, S Boas-Knoop, A Yahyazadeh, et al.
Clinical Transplantation|June 27, 1998
Orthotopic liver transplantation for hepatic associated metabolic disordersJ Pratschke, T Steinmüller, W O Bechstein, et al.
Clinical Transplantation|June 1, 1997
Liver transplantation: treatment of choice for hepatic and neurological manifestation of Wilson's diseaseG Schumacher, K P Platz, A R Mueller, et al.
Transplantation|October 31, 2001
Preoperative antiviral treatment and postoperative prophylaxis in HBV-DNA positive patients undergoing liver transplantationD Seehofer, N Rayes, U Naumann, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1997
Mycophenolate mofetil added to immunosuppression after liver transplantation--first resultsJ Klupp, W O Bechstein, K P Platz, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 26, 1999
Successful recanalization of late portal vein thrombosis after liver transplantation using systemic low-dose recombinant tissue plasminogen activatorO Guckelberger, W O Bechstein, J M Langrehr, et al.
Transplantation|June 27, 2000
Quadruple tacrolimus-based induction therapy including azathioprine and ALG does not significantly improve outcome after liver transplantation when compared with standard induction with tacrolimus and steroids: results of a prospective, randomized trialP Neuhaus, J Klupp, J M Langrehr, et al.
Zeitschrift Fur Gastroenterologie|November 10, 2000
[Therapy of recurrent hepatitis B infection after liver transplantation. A retrospective analysis of 200 liver transplantations based on hepatitis B associated liver diseases]D Seehofer, N Rayes, W O Bechstein, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
British Journal of Pharmacology|May 9, 2009
Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseasesH Schäcke, T M Zollner, W D Döcke, et al.
Zeitschrift Fur Gastroenterologie|September 1, 1992
[Orthotopic liver transplantation in hepatic cirrhosis: on the problem of infection of the transplant with persistent hepatitis viruses]U Hopf, P Neuhaus, V König, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 2, 2012
Role of mannose-binding lectin-2 polymorphism in the development of acute cellular rejection after transplantation for hepatitis C virus-induced liver diseaseD Eurich, S Boas-Knoop, A Yahyazadeh, et al.
Clinical Transplantation|June 27, 1998
Orthotopic liver transplantation for hepatic associated metabolic disordersJ Pratschke, T Steinmüller, W O Bechstein, et al.
Clinical Transplantation|June 1, 1997
Liver transplantation: treatment of choice for hepatic and neurological manifestation of Wilson's diseaseG Schumacher, K P Platz, A R Mueller, et al.
Transplantation|October 31, 2001
Preoperative antiviral treatment and postoperative prophylaxis in HBV-DNA positive patients undergoing liver transplantationD Seehofer, N Rayes, U Naumann, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1997
Mycophenolate mofetil added to immunosuppression after liver transplantation--first resultsJ Klupp, W O Bechstein, K P Platz, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 26, 1999
Successful recanalization of late portal vein thrombosis after liver transplantation using systemic low-dose recombinant tissue plasminogen activatorO Guckelberger, W O Bechstein, J M Langrehr, et al.
Transplantation|June 27, 2000
Quadruple tacrolimus-based induction therapy including azathioprine and ALG does not significantly improve outcome after liver transplantation when compared with standard induction with tacrolimus and steroids: results of a prospective, randomized trialP Neuhaus, J Klupp, J M Langrehr, et al.
Zeitschrift Fur Gastroenterologie|November 10, 2000
[Therapy of recurrent hepatitis B infection after liver transplantation. A retrospective analysis of 200 liver transplantations based on hepatitis B associated liver diseases]D Seehofer, N Rayes, W O Bechstein, et al.
Pageof 9